← Eichor
Study identifier: NCT06487273 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis

Condition: Non-cystic Fibrosis Bronchiectasis  ·  Sponsor: Physio-Assist

PhaseNA
Planned participants622
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Bronchiectasis is a chronic lung disease of multiple aetiologies characterised by permanent dilatation of the calibre of a territory of the bronchial tree with impaired mucociliary clearance. This alteration causes mucus retention, leading to infections and chronic bronchial inflammation. Respiratory physiotherapy is one of the cornerstones of the management of these patients, in particular to facilitate bronchial drainage. In patients with abundant bronchial secretions, it is recommended that bronchial drainage sessions be carried out on a daily or more frequent basis, which represents a very substantial burden in terms of care. In addition, access to respiratory physiotherapy is not always easy for patients due to geographical or time constraints or the availability of professionals. Moreover, few professionals are trained in this specific care for chronic lung diseases. SIMEOX (Physio-Assist, France) is an innovative medical device (CE medical mark) for draining the bronchial tree. By means of a mouthpiece, this device generates a succession of very short intermittent negative air pressure pulses which disseminate a pneumatic vibratory signal in the patient's bronchial tree, modifying the rheological properties of the mucus, facilitating the mobilisation of secretions and assisting their transport towards the upper airways. A recent pilot study demonstrated that the use of SIMEOX independently by the patient at home for 3 months, combined with remote Physiotherapy (1 ses…

This description comes directly from the study's public registry record.

Talk to the study team

Pauline Périnet-Marquet  ·  +33 7 63 23 66 15  ·  p.perinet-marquet@icadom.com

Laurent Morin  ·  +33 6 03 27 30 12  ·  laurent.morin@inogen.net

Always discuss trial participation with your own doctor first.

Locations (57)

CH AbbevilleAbbeville, FranceRecruiting
CH Aix en ProvenceAix-en-Provence, FranceRecruiting
CH AlbiAlbi, FranceRecruiting
Clinique Victor PauchetAmiens, FranceRecruiting
CHU Amiens PicardieAmiens, FranceRecruiting
CHU AngersAngers, FranceRecruiting
CH AnnecyAnnecy, FranceRecruiting
Clinique AressyAressy, FranceRecruiting
CHRU BrestBrest, FranceRecruiting
CH CotentinCherbourg, FranceRecruiting
CH Compiègne-NoyonCompiègne, FranceRecruiting
CH Alpes-LémanContamine-sur-Arve, FranceRecruiting

+ 45 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06487273